跳至主要内容
临床试验/ACTRN12621001352897
ACTRN12621001352897招募中未知

Investigating the feasibility of introducing personalised exercise prescription from point-of-diagnosis in individuals receiving treatment for early-stage breast or colon cancer in Christchurch, New Zealand.

niversity of Canterbury0 个研究点目标入组 90 人开始时间: 2021年10月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Men and women able to give informed written consent.
  • 18 years or older with adequate hematologic, renal and liver function.
  • Treatment for primary cancer; chemotherapy treatment, radiation therapy, or surgery commenced within the last twelve months
  • Good performance status (i.e. Eastern Cooperative Oncology Group (EGOC) performance status of 0–1).
  • Early stage breast or colon cancer (stage I-III, no distant metastasis).

排除标准

  • Acute infectious diseases.
  • Severe cardiovascular (e.g. unstable ischemic heart disease, uncontrolled arrhythmia) or respiratory (e.g. shortness of breath at rest) disease.
  • Severe anaemia (Hb<100).
  • Unable to read and speak English

研究者

发起方
niversity of Canterbury

相似试验